Back
Rocket Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
RCKT
Rocket Pharmaceuticals, Inc.
Last Price:
$3.28
Seasonality Move:
-13.93%
7 Day Trial
ALL ACCESS PASS
$
7
Rocket Pharmaceuticals, Inc. Stock Forecast
-
Is Rocket Pharmaceuticals, Inc. Stock Undervalued?The current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.27. The Score for RCKT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
RCKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Rocket Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Rocket Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Rocket Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rocketpharma.com
52-Week Data
52-Week High:
11.11
52-Week Low:
2.19
Prediction Charts
Market Cap:
353.9M
Price in USD:
3.27
Volume:
1.5M
Beta:
1.40
Technical Analysis
SMA50:
3.48
SMA100:
3.44
SMA200:
3.61
52-Wk Change:
-67.69%
Stock Predictions
-
Is Rocket Pharmaceuticals, Inc. stock public?Yes, Rocket Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Rocket Pharmaceuticals, Inc. stock quote today?The Rocket Pharmaceuticals, Inc. stock price is 3.27 USD today.
-
How to buy Rocket Pharmaceuticals, Inc. stock online?You can buy Rocket Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 3.63 | 3.65 | 3.74 | 3.54 |
| Jan-28 | 3.65 | 3.58 | 3.68 | 3.50 |
| Jan-29 | 3.54 | 3.55 | 3.59 | 3.50 |
| Jan-30 | 3.52 | 3.48 | 3.58 | 3.34 |
| Feb-2 | 3.45 | 3.48 | 3.63 | 3.38 |
| Feb-3 | 3.49 | 3.46 | 3.62 | 3.36 |
| Feb-4 | 3.48 | 3.33 | 3.50 | 3.28 |
| Feb-5 | 3.31 | 3.00 | 3.34 | 3.00 |
| Feb-6 | 3.10 | 3.16 | 3.22 | 3.07 |
| Feb-9 | 3.17 | 3.20 | 3.22 | 3.07 |
| Feb-10 | 3.19 | 3.24 | 3.32 | 3.18 |
| Feb-11 | 3.28 | 3.24 | 3.29 | 3.13 |
| Feb-12 | 3.25 | 3.25 | 3.26 | 3.08 |
| Feb-13 | 3.25 | 3.27 | 3.36 | 3.20 |
Rocket Pharmaceuticals, Inc. Earnings
Data Unavailable
Rocket Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.11 per share.
* Rocket Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.